Molecular editing of NSC-666719 enabling discovery of benzodithiazinedioxide-guanidines as anticancer agents

Authors:

Abstract
In this study, a unique strategy of scaffold-hopping-based molecular editing of a bioactive agent NSC-666719 was investigated, which led to the development of new benzodithiazinedioxide-guanidine based anticancer agents with Polβ inhibition.
Funding Information
  • Anusandhan National Research Foundation
  • Council of Scientific and Industrial Research, India
  • Cancer Center, University of Florida Health (P0280641)
  • Department of Biotechnology, Ministry of Science and Technology, India
  • Indian Council of Medical Research

This publication has 72 references indexed in Scilit: